arrow
H

Ho Kyung Seo

Korea University
H指数:27
被引数:3,310

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

COMPREHENSIVE MULTI-LAYERED OMICS ANALYSIS OF THE UBC LANDSCAPE FOR PRECISION MEDICINE AND ITS CLINICAL IMPLICATIONS: FROM DECIPHERING DISTINCT MOLECULAR HETEROGENEITY TO GUIDING TREATMENT DECISION-MAKING AND DEVELOPING TAILORED THERAPEUTIC STRATEGIES

对UBC景观进行全面的、多层次的组学分析以实现精准医学及其临床意义:从解析独特的分子异质性到指导治疗决策制定和开发定制的治疗策略

2026-05-010
PRE
EXTENDED CLINICAL OUTCOMES OF NEOADJUVANT INTRAVESICAL MITOMYCIN-C THERAPY ADMINISTERED IMMEDIATELY PRIOR TO TRANSURETHRAL RESECTION OF BLADDER TUMOR IN NON-MUSCLE INVASIVE BLADDER CANCER: OVER 3 YEARS OF FOLLOW-UP DATA FROM A RANDOMIZED PHASE II TRIAL

非肌层浸润性膀胱癌中,于经尿道膀胱肿瘤切除术前即刻给予新辅助膀胱内丝裂霉素-C疗法的扩展临床疗效:一项随机II期试验超过3年的随访数据

2026-05-010
PRE
Oncological outcomes of concurrent nephroureterectomy during radical cystectomy: A propensity score-matched analysis with multivariable adjustment from Korean multicenter database

根治性膀胱切除术期间同期行肾输尿管切除术的肿瘤学结果:一项基于韩国多中心数据库的倾向性评分匹配分析及多变量调整研究

2026-02-010
PRE
Novel syngeneic model of anti-mouse CLDN18.2 CAR-T therapy for gastric cancer demonstrates a synergy with TGF-β and PD-L1 inhibitors

新型同种异体模型研究抗小鼠CLDN18.2 CAR-T疗法对胃癌的治疗作用,并证明其与TGF-β和PD-L1抑制剂的协同效应

2025-12-010
OAAI
Demonstrating the non-inferiority of robotic radical cystectomy for cT3-cT4 urothelial carcinoma in the era of neoadjuvant chemotherapy: a propensity score-matched analysis

在辅助化疗时代的背景下,通过倾向性评分匹配分析,证明机器人辅助根治性膀胱切除术对于cT3-cT4尿路上皮癌的非劣效性。

2025-09-120
OA
Targeted Inhibition of O-Linked β-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder

靶向抑制O-连接的 β-n-乙酰氨基葡萄糖转移酶作为一种有前途的治疗策略,可恢复化学敏感性并减轻化学抗性膀胱尿路上皮癌的侵袭性肿瘤特征

2022-05-185
OAAI
The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up
2021-05-3114
OAAI